These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8898337)

  • 21. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
    Nirmalan N; Sims PF; Hyde JE
    Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors.
    Adane L; Bharatam PV
    Curr Med Chem; 2008; 15(16):1552-69. PubMed ID: 18673224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modeling of wild-type and antifolate resistant mutant Plasmodium falciparum DHFR.
    Delfino RT; Santos-Filho OA; Figueroa-Villar JD
    Biophys Chem; 2002 Aug; 98(3):287-300. PubMed ID: 12128181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.
    Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS
    ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-Hydrophobic aromatic substituent pyrimethamine analogues as potential antimalarials for pyrimethamine-resistant Plasmodium falciparum.
    Saepua S; Sadorn K; Vanichtanankul J; Anukunwithaya T; Rattanajak R; Vitsupakorn D; Kamchonwongpaisan S; Yuthavong Y; Thongpanchang C
    Bioorg Med Chem; 2019 Dec; 27(24):115158. PubMed ID: 31685330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum.
    Tarnchompoo B; Sirichaiwat C; Phupong W; Intaraudom C; Sirawaraporn W; Kamchonwongpaisan S; Vanichtanankul J; Thebtaranonth Y; Yuthavong Y
    J Med Chem; 2002 Mar; 45(6):1244-52. PubMed ID: 11881993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimalarial effect of cell penetrating peptides derived from the junctional region of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.
    Chaianantakul N; Sungkapong T; Supatip J; Kingsang P; Kamlaithong S; Suwanakitti N
    Peptides; 2020 Sep; 131():170372. PubMed ID: 32673701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors.
    Yuthavong Y; Yuvaniyama J; Chitnumsub P; Vanichtanankul J; Chusacultanachai S; Tarnchompoo B; Vilaivan T; Kamchonwongpaisan S
    Parasitology; 2005 Mar; 130(Pt 3):249-59. PubMed ID: 15796007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.
    Sirawaraporn W; Sathitkul T; Sirawaraporn R; Yuthavong Y; Santi DV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1124-9. PubMed ID: 9037017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
    Biswas S
    Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
    de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
    Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
    Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH
    Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
    Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
    Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel antifolate resistant mutations of Plasmodium falciparum dihydrofolate reductase selected in Escherichia coli.
    Chusacultanachai S; Thiensathit P; Tarnchompoo B; Sirawaraporn W; Yuthavong Y
    Mol Biochem Parasitol; 2002 Mar; 120(1):61-72. PubMed ID: 11849706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium falciparum: asparagine mutant at residue 108 of dihydrofolate reductase is an optimal antifolate-resistant single mutant.
    Sirawaraporn W; Yongkiettrakul S; Sirawaraporn R; Yuthavong Y; Santi DV
    Exp Parasitol; 1997 Nov; 87(3):245-52. PubMed ID: 9371090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
    Fidock DA; Nomura T; Wellems TE
    Mol Pharmacol; 1998 Dec; 54(6):1140-7. PubMed ID: 9855645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
    Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum.
    Sirichaiwat C; Intaraudom C; Kamchonwongpaisan S; Vanichtanankul J; Thebtaranonth Y; Yuthavong Y
    J Med Chem; 2004 Jan; 47(2):345-54. PubMed ID: 14711307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.